SNT
Click for more information
7.89% 4.1¢ syntara limited

myelodysplastic syndromes (MDS) is a $3.5b market and Syntara...

  1. newB
    6,935 Posts.
    lightbulb Created with Sketch. 520
    clock Created with Sketch.
    14/02/24
    21:43
    Post #: 72411408
    myelodysplastic syndromes (MDS) is a $3.5b market and Syntara only need to contribute 700k, more importantly it go straight into Phase 2 later this year.
    This is substantially more commercialized focus and less time consuming than the previous myelofibrosis trails.
    Not sure how long it'll take before the market realize this.
    SNT Price at posting: 2.3¢ Sentiment: None Disclosure: Held
    Likes Created with Sketch. 3  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Warren Tredrea’s weekly sports business wrap: the latest on business in sport
right-arrow Created with Sketch.
TRP Tissue Repairs soars nearly 32% on TGA approval for wound healing gel
right-arrow Created with Sketch.
LKE Lake Resources implies news article on job cuts made up; non-core sales "not material" and no rule 15.7 breach
right-arrow Created with Sketch.
NEWS Real estate dynamics & changes raise investor doubt
right-arrow Created with Sketch.
MM1 Geochemical work at Newington picks up gold and copper anomalies for Midas
right-arrow Created with Sketch.
FMG Quarterly & half yearly reports: Drives Newmont up, Ampol flat, while Fortescue plunges 2.6%
right-arrow Created with Sketch.
watchlist Created with Sketch. Add SNT (ASX) to my watchlist
(20min delay)
Last
4.1¢ 		Change
0.003(7.89%) 		Mkt cap ! $48.95M
Open High Low Value Volume
3.8¢ 4.1¢ 3.6¢ $42.31K 1.111M

Buyers (Bids)

No. Vol. Price($)
1 100000 3.9¢
 

Sellers (Offers)

Price($) Vol. No.
4.1¢ 149088 1
View Market Depth
Last trade - 16.10pm 25/07/2024 (20 minute delay) ?
SNT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.